EBIT at other companies
Other financials
Where this comes from
Calculated from Dogwood Therapeutics’s reported figures.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's EBIT?
- Dogwood Therapeutics (DWTX) reported EBIT of -$5.08M in Q1 2026.
- How has Dogwood Therapeutics's EBIT changed year-over-year?
- Dogwood Therapeutics's EBIT decreased by 14.6% year-over-year, from -$4.43M to -$5.08M.
- What is the long-term trend for Dogwood Therapeutics's EBIT?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's EBIT has grown at a 15.6% compound annual growth rate (CAGR), from -$15.64M to -$27.97M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.